Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misocholic Tab in Non-Viral Elevated Liver Enzymes
NCT07833514Phase 3Not yet recruiting
- Sponsor
- Hanoi Medical University
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of Misocholic Tab in alcoholic liver disease (ALD), drug induced liver injury (DILI), non-alcoholic fatty liver disease (NAFLD), sponsored by Hanoi Medical University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Misocholic Tab
03
Conditions
alcoholic liver disease (ALD)drug induced liver injury (DILI)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT07833514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07833514.